Two newly-emerging substituted phenethylamines MAL and BOD induce differential psychopharmacological effects in rodents.


Journal

Journal of psychopharmacology (Oxford, England)
ISSN: 1461-7285
Titre abrégé: J Psychopharmacol
Pays: United States
ID NLM: 8907828

Informations de publication

Date de publication:
09 2020
Historique:
pubmed: 11 7 2020
medline: 5 11 2021
entrez: 11 7 2020
Statut: ppublish

Résumé

Recently, the recreational use of substituted phenethylamines has grown rapidly. Among these are 2-(3,5-dimethoxy-4-((2-methylallyl)oxy)phenyl)ethanamine (MAL) and 2-(2,5-dimethoxy-4-methylphenyl)-2-methoxyethan-1-amine (BOD). However, studies characterizing their abuse potential are still lacking. The purpose of this study was to investigate the abuse potential of MAL and BOD. The psychostimulant, reinforcing, and rewarding properties of MAL and BOD were analyzed using locomotor sensitization, self-administration, and conditioned place preference tests. Dopamine antagonists (i.e. SCH23390, haloperidol) were administered during conditioned place preference to evaluate the involvement of the mesolimbic dopamine system. Furthermore, dopamine-related protein expression in the nucleus accumbens and the ventral tegmental area was measured along with dopamine concentrations in the nucleus accumbens. Electroencephalography was conducted to determine effects of MAL and BOD on brain wave activity. MAL induced psychostimulant effects and sensitization, while BOD induced locomotor depression in mice. Only MAL was self-administered by rats. Both drugs induced conditioned place preference in mice at different doses; dopamine receptor antagonists blocked MAL- and BOD-induced conditioned place preference. Both the compounds altered the expression of dopamine receptor D MAL may induce abuse potential via the mesolimbic dopaminergic system and possibly accompanied by alterations in brain wave activity. Moreover, the lack of rewarding and reinforcing effects in BOD suggest that this drug may have little to no capability to engender compulsive behavior, though having found to induce alterations in dopaminergic system and brain wave activities.

Sections du résumé

BACKGROUND
Recently, the recreational use of substituted phenethylamines has grown rapidly. Among these are 2-(3,5-dimethoxy-4-((2-methylallyl)oxy)phenyl)ethanamine (MAL) and 2-(2,5-dimethoxy-4-methylphenyl)-2-methoxyethan-1-amine (BOD). However, studies characterizing their abuse potential are still lacking.
AIM
The purpose of this study was to investigate the abuse potential of MAL and BOD.
METHODS
The psychostimulant, reinforcing, and rewarding properties of MAL and BOD were analyzed using locomotor sensitization, self-administration, and conditioned place preference tests. Dopamine antagonists (i.e. SCH23390, haloperidol) were administered during conditioned place preference to evaluate the involvement of the mesolimbic dopamine system. Furthermore, dopamine-related protein expression in the nucleus accumbens and the ventral tegmental area was measured along with dopamine concentrations in the nucleus accumbens. Electroencephalography was conducted to determine effects of MAL and BOD on brain wave activity.
RESULTS
MAL induced psychostimulant effects and sensitization, while BOD induced locomotor depression in mice. Only MAL was self-administered by rats. Both drugs induced conditioned place preference in mice at different doses; dopamine receptor antagonists blocked MAL- and BOD-induced conditioned place preference. Both the compounds altered the expression of dopamine receptor D
CONCLUSIONS
MAL may induce abuse potential via the mesolimbic dopaminergic system and possibly accompanied by alterations in brain wave activity. Moreover, the lack of rewarding and reinforcing effects in BOD suggest that this drug may have little to no capability to engender compulsive behavior, though having found to induce alterations in dopaminergic system and brain wave activities.

Identifiants

pubmed: 32648801
doi: 10.1177/0269881120936458
doi:

Substances chimiques

Central Nervous System Stimulants 0
DRD2 protein, mouse 0
Dopamine Antagonists 0
Drd1 protein, mouse 0
Phenethylamines 0
Receptors, Dopamine D1 0
Receptors, Dopamine D2 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1056-1067

Auteurs

Raly James Perez Custodio (RJP)

Uimyung Research Institute for Neuroscience, Sahmyook University, Seoul, Republic of Korea.

Leandro Val Sayson (LV)

Uimyung Research Institute for Neuroscience, Sahmyook University, Seoul, Republic of Korea.

Chrislean Jun Botanas (CJ)

Uimyung Research Institute for Neuroscience, Sahmyook University, Seoul, Republic of Korea.

Arvie Abiero (A)

Uimyung Research Institute for Neuroscience, Sahmyook University, Seoul, Republic of Korea.

Mikyung Kim (M)

Uimyung Research Institute for Neuroscience, Sahmyook University, Seoul, Republic of Korea.
Department of Chemistry and Life Science, Sahmyook University, Seoul, Republic of Korea.

Hyun Jun Lee (HJ)

Uimyung Research Institute for Neuroscience, Sahmyook University, Seoul, Republic of Korea.

Hye Won Ryu (HW)

Medicinal Chemistry Laboratory, Kyung Hee University, Seoul, Republic of Korea.

Yong Sup Lee (YS)

Medicinal Chemistry Laboratory, Kyung Hee University, Seoul, Republic of Korea.

Hee Jin Kim (HJ)

Uimyung Research Institute for Neuroscience, Sahmyook University, Seoul, Republic of Korea.

Jae Hoon Cheong (JH)

Uimyung Research Institute for Neuroscience, Sahmyook University, Seoul, Republic of Korea.
School of Pharmacy, Jeonbuk National University, Jeollabuk-do, Republic of Korea.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH